Archit Organosys (BOM:524640) Other Stockholders Equity: ₹557 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524640 Archit Organosys Ltd BOM:524640
63 GF Score
Price ₹62.29
GF Value ₹55.42
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Archit Organosys Other Stockholders Equity?

Archit Organosys BOM:524640 +1.98% 63 Other Stockholders Equity is ₹557 Mil as of Mar. 2026. GuruFocus rates BOM:524640 with a GF Score™ of 63/100 and a GF Value™ of ₹55.42 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Archit Organosys's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹557 Mil.

Archit Organosys's quarterly Other Stockholders Equity declined from Sep. 2025 (₹523 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹557 Mil).

Archit Organosys's annual Other Stockholders Equity increased from Mar. 2024 (₹1 Mil) to Mar. 2025 (₹1 Mil) and increased from Mar. 2025 (₹1 Mil) to Mar. 2026 (₹557 Mil).

Archit Organosys Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Archit Organosys's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Archit Organosys Other Stockholders Equity Chart

Archit Organosys Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 412.55 1.03 1.03 557.12

Archit Organosys Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.00 522.60 0.00 557.12
BOM:524640
63GF Score
Archit Organosys Ltd BOM:524640
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Archit Organosys Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹557 Mil mean?
Archit Organosys (BOM:524640) has a Other Stockholders Equity of ₹557 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Archit Organosys and its competitors.
Is Archit Organosys' Other Stockholders Equity too high?
Archit Organosys' current Other Stockholders Equity is ₹557 Mil. Overall, Archit Organosys has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' Other Stockholders Equity compare to DOW?
Archit Organosys' Other Stockholders Equity of ₹557 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Archit Organosys and its competitors. Archit Organosys's current Other Stockholders Equity is ₹557 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.42, compared to a current price of ₹62.29 — trading 12.4% above its estimated fair value. The current Other Stockholders Equity is ₹557 Mil. Archit Organosys' overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current Other Stockholders Equity is ₹557 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Archit Organosys (BOM:524640) Overvalued in 2026?

Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued. The current stock price of ₹62.29 is trading 12.4% above its estimated GF Value™ of ₹55.42. GuruFocus considers Archit Organosys to be Modestly Overvalued.

Key valuation signals for BOM:524640:

  • Other Stockholders Equity: ₹557 Mil
  • GF Value™: ₹55.42 vs. price of ₹62.29 (12.4% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Archit Organosys Business Description

Address S. G. Highway, 9th Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, Ahmedabad, GJ, IND, 380054
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
63GF Score

Get the complete analysis for BOM:524640

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹62.29
Price
₹55.42
GF Value